The FDA’s Commissioner’s National Priority Voucher program, unveiled in June 2025, is “shrouded in secrecy,” Democratic ...
Chugai Pharmaceutical Co. fell 7.3%, the largest intraday decline since August 2025, after the company said it had ended the ...
The blockbuster weight loss drug sold as Ozempic and Wegovy will soon go generic in countries that are home to 40% of the ...
Structure Therapeutics advances oral therapies for diabetes, obesity, and pulmonary disease through its clinical-stage drug ...
Morning Overview on MSN
Python blood compound is being studied for potential weight loss drugs
Researchers at the University of Colorado Boulder have identified a molecule in Burmese python blood that suppresses appetite ...
Wall Street and healthcare stocks sank as Eli Lilly was downgraded, Novo’s Wegovy HD won FDA approval, and drug supply risks rose.
GLP-1 medications like semaglutide (Ozempic) may offer unexpected mental health benefits alongside weight loss. A large study ...
In that vein, Bitcoin (CRYPTO: BTC) and Viking Therapeutics (NASDAQ: VKTX) sit at opposite ends of the asset spectrum, with ...
After losing more than 100 pounds following gastric surgery, he tried Ozempic for a while, but the side effects were too much ...
A surprising new study suggests that a drug first designed for brain and blood diseases might also help people lose weight ...
Retatrutide, an experimental diabetes drug, reduced A1C levels by 2 percent and body weight by 17 percent in a new late-stage ...
The GLP-1 PR has been a little too good. Everyone knows the drugs lead to rapid weight loss — including participants in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results